Literature DB >> 17192308

Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Qiang Deng1, Jian-wei Zhai, Marie-Louise Michel, Jun Zhang, Jun Qin, Yu-ying Kong, Xin-xin Zhang, Agata Budkowska, Pierre Tiollais, Yuan Wang, You-hua Xie.   

Abstract

A direct involvement of the PreS domain of the hepatitis B virus (HBV) large envelope protein, and in particular amino acid residues 21 to 47, in virus attachment to hepatocytes has been suggested by many previous studies. Several PreS-interacting proteins have been identified. However, they share few common sequence motifs, and a bona fide cellular receptor for HBV remains elusive. In this study, we aimed to identify PreS-interacting motifs and to search for novel HBV-interacting proteins and the long-sought receptor. PreS fusion proteins were used as baits to screen a phage display library of random peptides. A group of PreS-binding peptides were obtained. These peptides could bind to amino acids 21 to 47 of PreS1 and shared a linear motif (W1T2X3W4W5) sufficient for binding specifically to PreS and viral particles. Several human proteins with such a motif were identified through BLAST search. Analysis of their biochemical and structural properties suggested that lipoprotein lipase (LPL), a key enzyme in lipoprotein metabolism, might interact with PreS and HBV particles. The interaction of HBV with LPL was demonstrated by in vitro binding, virus capture, and cell attachment assays. These findings suggest that LPL may play a role in the initiation of HBV infection. Identification of peptides and protein ligands corresponding to LPL that bind to the HBV envelope will offer new therapeutic strategies against HBV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192308      PMCID: PMC1866126          DOI: 10.1128/JVI.01270-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.

Authors:  Xinxiu Yang; Weiguo Hu; Feng Li; Hengchuan Xia; Zuchuan Zhang
Journal:  Protein Expr Purif       Date:  2005-06       Impact factor: 1.650

2.  The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface.

Authors:  P Pontisso; M G Ruvoletto; C Tiribelli; W H Gerlich; A Ruol; A Alberti
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

Review 3.  Cell entry of hepatitis C virus.

Authors:  Birke Bartosch; François-Loïc Cosset
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

4.  Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts.

Authors:  Elena Makoveichuk; Susanna Castel; Senen Vilaró; Gunilla Olivecrona
Journal:  Biochim Biophys Acta       Date:  2004-11-08

5.  Expression and purification of the complete PreS region of hepatitis B Virus.

Authors:  Qiang Deng; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

6.  Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.

Authors:  H van Tilbeurgh; A Roussel; J M Lalouel; C Cambillau
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

7.  Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.

Authors:  E Vilella; J Joven; M Fernández; S Vilaró; J D Brunzell; T Olivecrona; G Bengtsson-Olivecrona
Journal:  J Lipid Res       Date:  1993-09       Impact factor: 5.922

8.  Cloning and characterization of a novel human hepatocyte transcription factor, hB1F, which binds and activates enhancer II of hepatitis B virus.

Authors:  M Li; Y H Xie; Y Y Kong; X Wu; L Zhu; Y Wang
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

9.  Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.

Authors:  A Budkowska; C Quan; F Groh; P Bedossa; P Dubreuil; J P Bouvet; J Pillot
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis.

Authors:  P Ostapchuk; P Hearing; D Ganem
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  15 in total

1.  How the key finds its door - identification of HBV receptor.

Authors:  Yun Wang; Xinwen Chen
Journal:  Virol Sin       Date:  2013-01-16       Impact factor: 4.327

Review 2.  Deciphering the mystery of hepatitis B virus receptors: A historical perspective.

Authors:  Zaira Rehman; Ammad Fahim; Hajra Sadia
Journal:  Virusdisease       Date:  2015-07-03

3.  Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Authors:  Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 4.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 5.  Development of novel therapeutics for chronic hepatitis B.

Authors:  You-hua Xie; Ran Hong; Wei Liu; Jing Liu; Jian-wei Zhai
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

6.  Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.

Authors:  Ying Gu; Xuhua Tang; Xiao Zhang; Cuiling Song; Minghua Zheng; Kaihang Wang; Jun Zhang; Mun-Hon Ng; Choy-Leong Hew; Shaowei Li; Ningshao Xia; J Sivaraman
Journal:  Cell Res       Date:  2015-03-20       Impact factor: 25.617

7.  Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection.

Authors:  Xiaochen Tian; Chao Zhao; Hongguang Zhu; Weimin She; Jiming Zhang; Jing Liu; Lanjuan Li; Shusen Zheng; Yu-Mei Wen; Youhua Xie
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Authors:  Ran Hong; Weiya Bai; Jianwei Zhai; Wei Liu; Xinyan Li; Jiming Zhang; Xiaoxian Cui; Xue Zhao; Xiaoli Ye; Qiang Deng; Pierre Tiollais; Yumei Wen; Jing Liu; Youhua Xie
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 9.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 10.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.